Cases & Deals

Aprea Therapeutics completes $97 million IPO

Clients Aprea Therapeutics, Inc.

Jones Day served as IP counsel in connection with the $97 million initial public offering of Aprea Therapeutics, Inc. (NASDAQ: APRE). Aprea Therapeutics is a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53.